Arthritis is a common ailment that afflicts many older adults. Nuvo Pharmaceuticals Inc. (TSE:NRI) has developed a FDA approved topical solution for treating osteoarthritis of the knee without having to swallow a pill. Its CEO, John London, spoke with SmallCapPower at the recent Bloom Burton & Co. Healthcare Investor Conference. Find out more about this Company’s global growth strategy by watching our short video interview.
Click here for more Companies to Watch from the Bloom Burton & Co. Healthcare Investor Conference!
